What is Luis Ortiz-Espinosa's NPI number?

Luis Ortiz-Espinosa's National Provider Identifier (NPI) is 1053390732, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Luis Ortiz-Espinosa's specialty?

Luis Ortiz-Espinosa is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).

Where is Luis Ortiz-Espinosa located?

Luis Ortiz-Espinosa's practice location on file with NPPES is Pq-28 Ave. El Comandante, Carolina, PR 00983.

What is Luis Ortiz-Espinosa's phone number?

The practice phone number listed in the NPPES registry for Luis Ortiz-Espinosa is (787) 752-3280.

Does Luis Ortiz-Espinosa accept Medicare?

Luis Ortiz-Espinosa is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Luis Ortiz-Espinosa's NPI active?

Yes — Luis Ortiz-Espinosa's NPI (1053390732) is active in the NPPES registry as of the last update on 2017-05-11.

IndividualActiveAccepts Medicare

Luis Ortiz-Espinosa, M.D., FAAD

NPI 1053390732 · Dermatology Physician · Carolina, PR

Luis Ortiz-Espinosa, M.D., FAAD is a Dermatology Physician provider in Carolina, PR (NPI 1053390732).

Provider details

NPI number: 1053390732
Entity type: Individual
Primary specialty: Dermatology PhysicianAllopathic & Osteopathic Physicians
Credential: M.D., FAAD
Sex: Male
Sole proprietor: No
License: 9468 (PR)

Practice location

Pq-28 Ave. El Comandante

Country Club

Carolina, PR 00983

Phone: (787) 752-3280

Fax: (787) 752-8920

More PR providers

Mailing address

90 Ave. Rio Hondo Pmb 126

Bayamon, PR 00961

Specialties & taxonomies

Dermatology PhysicianPrimary207N00000XLicense 9468 (PR)
Allopathic & Osteopathic Physicians

Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Established profile(74/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
20 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
1 documented practice location
Medicare service volume (vs. specialty peers)25% of score
1,473 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 15 Or More Growths17004	300	$164
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	292	$90
Injection Into Skin Growth, More Than 7 Growths11901	153	$39
Destruction of Birthmark, More Than 50.0 Sq Cm17108	152	$627
Biopsy of Related Skin Growth, First Growth11102	134	$60
Destruction of Precancer Skin Growth, 2-14 Growths17003	117	$7

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 50 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Mupirocin	899	716
Ammonium Lactate	641	469
Clobetasol Propionate	501	294
Ketoconazole	269	168
Betamethasone Valerate	223	164
Fluocinolone/Shower Capbrand: Fluocinolone Acetonide	169	118
Ciclopirox	163	117
Hydroxyzine Hcl	140

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$2,038 across 52 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2006-01-11
Last updated: 2017-05-11

Frequently asked questions

What is Luis Ortiz-Espinosa's NPI number?: Luis Ortiz-Espinosa's National Provider Identifier (NPI) is 1053390732, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Luis Ortiz-Espinosa's specialty?: Luis Ortiz-Espinosa is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).
Where is Luis Ortiz-Espinosa located?: Luis Ortiz-Espinosa's practice location on file with NPPES is Pq-28 Ave. El Comandante, Carolina, PR 00983.
What is Luis Ortiz-Espinosa's phone number?: The practice phone number listed in the NPPES registry for Luis Ortiz-Espinosa is (787) 752-3280.
Does Luis Ortiz-Espinosa accept Medicare?: Luis Ortiz-Espinosa is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Luis Ortiz-Espinosa's NPI active?: Yes — Luis Ortiz-Espinosa's NPI (1053390732) is active in the NPPES registry as of the last update on 2017-05-11.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 15 Or More Growths17004	300	$164
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	292	$90
Injection Into Skin Growth, More Than 7 Growths11901	153	$39
Destruction of Birthmark, More Than 50.0 Sq Cm17108	152	$627
Biopsy of Related Skin Growth, First Growth11102	134	$60
Destruction of Precancer Skin Growth, 2-14 Growths17003	117	$7

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 50 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Mupirocin	899	716
Ammonium Lactate	641	469
Clobetasol Propionate	501	294
Ketoconazole	269	168
Betamethasone Valerate	223	164
Fluocinolone/Shower Capbrand: Fluocinolone Acetonide	169	118
Ciclopirox	163	117
Hydroxyzine Hcl	140

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$2,038 across 52 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments